Danaher Corporation (DHR) Among Most Oversold Stocks, Gains Attention with Strategic Biotech Moves

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Danaher Corporation is one of them. Danaher Corporation (NYSE:DHR), a global leader in life sciences and diagnostics, continues to advance its bioprocessing, diagnostics, and life sciences segments through innovation and strategic partnerships. In Q2 2025, the company marked its eighth consecutive quarter of increased orders in bioprocessing, driven by strong demand for consumables from major pharmaceutical ...